News

A recent study led by Andrew Sauer, M.D., cardiologist at Saint Luke’s Mid America Heart Institute, showed that for patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves patient care.

After a fainting spell, Angela Alvarez was ultimately diagnosed with cardiomyopathy and congestive heart failure. Her original plan of action was to undergo a heart transplant, but she sought a second opinion at Saint Luke’s Mid America Heart Institute.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.

When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.

For people age 60 or older, or who have a family history of heart disease, one simple test and a matter of minutes can determine the potential risk of a future heart attack.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

The Wall Street Journal invited Dr. James O’Keefe, MD, director of preventive cardiology at Saint Luke’s Mid America Heart Institute, to explain the potential risk and share tips on how you can protect your heart during the big game.

Empower yourself by learning all you can about therapies for multiple sclerosis.

Ahead of American Heart Month, USA Today talks with Dr. James O’Keefe of the Saint Luke’s Mid America Heart Institute about five steps you can take to reduce your risk of developing heart disease.